Therapeutic method and method for making compositions for use therein
CA 1186994 A · Owner: Baxter Travenol Laboratories, Inc. · Inventors: Thomas, William R.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Patients having a clotting factor defect can be successfully treated by the administration of a composition containing effective hemostatic amounts of factor VIIa. Preferably the factor VIIa, is substantially free of factors IXa and Xa. Procedures for preparing the above therapeutic compositions are also described.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Granted May 14, 1985. A Canadian patent filed before October 1, 1989 lasted 17 years from grant, so its term ended May 14, 2002.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.